Comparison of Voice Results at 5 Years of Treatment of Glottic Squamous

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Patients with early-stage squamous cell carcinomas of the vocal cord can be treated in an equivalent way in terms of carcinology by surgery or radiotherapy. The study will be to analyse the vocal outcome at 5 years of these two types of management in order to define whether one is superior to the other on this criterion of voice quality after treatment.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05688488` - Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords	Phase 1/Phase 2
Active, not recruiting	`NCT03548285` - Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer	N/A
Recruiting	`NCT05679856` - Vocal Cord vs Whole Laryngeal Radiotherapy for T1aN0 Glottic Cancer	N/A
Recruiting	`NCT04908696` - Clinical Treatments in Specialized Disease of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)

NCT number	NCT04447456
Study type	Observational
Source	University Hospital, Lille
Contact
Status	Completed
Phase
Start date	November 3, 2020
Completion date	January 19, 2022

Comparison of Voice Results at 5 Years of Treatment of Glottic Squamous Cell Carcinoma T1 by Surgery Versus Radiotherapy — VO Qual

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms